VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2020 | SEMITEP: reducing testicular cancer chemo

Yohann Loriot, MD, PhD, Gustave Roussy Institute & University of Paris-Saclay, Paris, France, outlines the SEMITEP trial (NCT01887340): de-escalating chemotherapy in low-volume metastatic seminoma based on early FDG-PET. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter